Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer? A gynecologic oncology group ancillary data analysis

Authors :: Moore, Kathleen N.
Tian, Chunqiao
McMeekin, D. Scott
Thigpen, J. Tate
Randall, Marcus E.
Gallion, Holly H.
Source :: Cancer. Dec 1, 2010, Vol. 116 Issue 23, p5407, 8 p.
Publication Year :: 2010

Subjects :: Endometrial cancer -- Care and treatment
Endometrial cancer -- Patient outcomes
Endometrial cancer -- Research
Chemotherapy -- Patient outcomes
Chemotherapy -- Research
Cancer -- Chemotherapy
Cancer -- Patient outcomes
Cancer -- Research
Health

Tools